Approval · Notice of Compliance 25772 · 2021
UPTRAVI: Notice of Compliance 25772
Issued May 3, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25772
- Date
- May 3, 2021
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the blister pack labels and remove actelion name (logo)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| UPTRAVI | Not yet assigned | — |